title: Tumor heterogeneity, clonal evolution, and therapy resistance: an opportunity for multitargeting therapy.
abstract: Heterogeneity within the cell population is a feature of many tumors. This lack of cellular homogeneity may originate from a number of sources, including differential nutrient status due to the de novo microcirculations of tumors, to infiltration of normal cells into the tumor, and to the hierarchical natures of the cell populations from which cancers arise. Tumors are thought to arise from one or more tumor initiating cells (TIC) within the population and to found hierarchies of progenitors and more differentiated cancer cells. TIC are often derived from tissue stem cells and these cancer stem cells are characterized by resistance to most cytotoxic treatments and by a high metastatic rate. Many of the properties of tumor populations, including the ability to express mutated oncogenes and to evolve new features such as treatment resistance and invasive and metastatic potential appear to depend on the molecular chaperone Hsp90. We discuss the potential of targeting the heterogeneous cell population with Hsp90 inhibitory drugs and its potential ability to inactivate TIC and to block the evolution of new phenotypes in cancer.
authors.affiliation: Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA. scalderw@bidmc.harvard.edu
authors.forename: Stuart K
authors.initials: SK
authors.lastname: Calderwood
mesh_terms: D060965:Clonal Evolution; D014644:Genetic Variation; D018841:HSP90 Heat-Shock Proteins / Q000037:antagonists & inhibitors; D006801:Humans; D018832:Molecular Chaperones / Q000378:metabolism; D009154:Mutation; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics* / Q000378:metabolism; D014411:Neoplastic Stem Cells / Q000166:cytology / Q000473:pathology; D009857:Oncogenes; D010641:Phenotype; D013234:Stem Cells / Q000166:cytology
chemical_list: D018841:HSP90 Heat-Shock Proteins; D018832:Molecular Chaperones
references.citation: Hum Pathol. 2013 Mar;44(3):402-11
references.pmid: 23036368
references.citation: Nature. 1998 Nov 26;396(6709):336-42
references.pmid: 9845070
references.citation: Curr Opin Genet Dev. 1995 Jun;5(3):382-95
references.pmid: 7549435
references.citation: Curr Opin Genet Dev. 2006 Feb;16(1):92-9
references.pmid: 16343892
references.citation: Nature. 2003 Sep 25;425(6956):407-10
references.pmid: 14508491
references.citation: Arch Toxicol. 2013 Jan;87(1):19-48
references.pmid: 22885793
references.citation: Gerontology. 2009;55(5):550-8
references.pmid: 19546513
references.citation: Stem Cells Dev. 2009 Sep;18(7):1093-108
references.pmid: 19480567
references.citation: Nat Rev Cancer. 2011 Sep 23;11(10):726-34
references.pmid: 21941284
references.citation: Nat Rev Cancer. 2008 Jul;8(7):491-5
references.pmid: 18511936
references.citation: Scientifica (Cairo). 2013;2013:217513
references.pmid: 24278769
references.citation: Nat Rev Cancer. 2005 Oct;5(10):761-72
references.pmid: 16175177
references.citation: Nature. 2012 Jan 18;481(7381):287-94
references.pmid: 22258607
references.citation: Stem Cells. 2012 Aug;30(8):1624-33
references.pmid: 22696450
references.citation: Genes Dev. 2009 Nov 15;23(22):2563-77
references.pmid: 19933147
references.citation: Neuro Oncol. 2009 Apr;11(2):109-21
references.pmid: 18682579
references.citation: Cell. 2011 Mar 4;144(5):646-74
references.pmid: 21376230
references.citation: Front Biosci (Schol Ed). 2011 Jun 01;3:1486-99
references.pmid: 21622284
references.citation: Oncogene. 2013 Aug 1;32(31):3569-76
references.pmid: 23160373
references.citation: Cancer Sci. 2010 Jun;101(6):1417-23
references.pmid: 20331635
references.citation: Stem Cell Rev. 2008 Summer;4(2):119-24
references.pmid: 18493880
references.citation: Methods Mol Biol. 2011;787:45-66
references.pmid: 21898226
references.citation: Bioessays. 2013 Mar;35(3):253-60
references.pmid: 23027425
references.citation: Oncogene. 2011 Sep 29;30(39):4075-86
references.pmid: 21499308
references.citation: Breast Cancer Res. 2012 Jan 25;14(1):R18
references.pmid: 22277639
references.citation: Cancer Lett. 2012 Apr 1;317(1):78-88
references.pmid: 22085491
references.citation: J Clin Invest. 2013 Jan;123(1):189-205
references.pmid: 23318994
references.citation: Cell Stem Cell. 2007 Nov;1(5):555-67
references.pmid: 18371393
references.citation: Trends Mol Med. 2002;8(4 Suppl):S55-61
references.pmid: 11927289
references.citation: Carcinogenesis. 2009 Jul;30(7):1073-81
references.pmid: 19468060
references.citation: J Cell Biochem. 2012 Apr;113(4):1096-103
references.pmid: 22105880
references.citation: J Biol Chem. 2005 Apr 1;280(13):13148-52
references.pmid: 15671027
references.citation: Blood. 2007 Jul 15;110(2):678-85
references.pmid: 17395781
references.citation: Exp Cell Res. 2013 Mar 10;319(5):600-11
references.pmid: 23246572
references.citation: Oncogene. 2009 Oct 22;28(42):3689-701
references.pmid: 19668225
references.citation: Cancer Res. 2007 Dec 15;67(24):11942-50
references.pmid: 18089825
references.citation: J Cell Sci. 2012 Sep 1;125(Pt 17):3939-48
references.pmid: 23104738
references.citation: Mutat Res. 2005 Jan 6;569(1-2):75-85
references.pmid: 15603753
references.citation: Nature. 2002 Jun 6;417(6889):618-24
references.pmid: 12050657
references.citation: Nat Rev Cancer. 2012 Mar 15;12(4):298-306
references.pmid: 22419253
references.citation: Nature. 2001 Nov 1;414(6859):105-11
references.pmid: 11689955
references.citation: Methods Enzymol. 2007;435:297-321
references.pmid: 17998060
references.citation: Cell Cycle. 2010 Apr 15;9(8):1542-50
references.pmid: 20372081
references.citation: Cold Spring Harb Symp Quant Biol. 2005;70:479-82
references.pmid: 16869786
references.citation: Nature. 2003 Sep 25;425(6956):357-9
references.pmid: 14508471
references.citation: Nat Rev Cancer. 2010 Aug;10(8):537-49
references.pmid: 20651736
references.citation: Annu Rev Med. 2006;57:1-18
references.pmid: 16409133
references.citation: Nature. 2011 Dec 07;481(7379):85-9
references.pmid: 22158103
references.citation: Curr Mol Med. 2012 Nov 1;12(9):1108-24
references.pmid: 22804235
references.citation: Nat Rev Cancer. 2009 Apr;9(4):265-73
references.pmid: 19262571
references.citation: Genes Dev. 2003 May 15;17(10):1253-70
references.pmid: 12756227
references.citation: Clin Cancer Res. 2012 Jan 1;18(1):64-76
references.pmid: 22215907
references.citation: Nature. 2009 Jan 1;457(7225):36-7
references.pmid: 19122629
references.citation: Cancer Res. 2010 Jan 15;70(2):697-708
references.pmid: 20068175
references.citation: Stem Cells. 2012 Dec;30(12):2645-56
references.pmid: 22968989
references.citation: Cancer Res. 2012 Sep 1;72(17):4551-61
references.pmid: 22751135
references.citation: Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):2784-9
references.pmid: 22308314
references.citation: Nature. 2012 Jan 18;481(7381):306-13
references.pmid: 22258609
references.citation: Stem Cells. 2012 May;30(5):833-44
references.pmid: 22489015
references.citation: Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):2963-8
references.pmid: 18287065
references.citation: Science. 1956 Feb 24;123(3191):309-14
references.pmid: 13298683